Individual dose prescription and dose escalation with intraoperative radiotherapy (IORT) in patients with soft tissue sarcomas of the limb to counteract risk factors for local recurrence

被引：0
|
作者：
Roeper, B. [1 ]
Rechl, H. [2 ]
Schindler, E. M. [3 ]
Hadjamu, M. [1 ]
Winkler, C. [1 ]
Kneschaurek, P. [1 ]
Molls, M. [1 ]
Gradinger, R. [2 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Klin Strahlentherapie & Radiol Onkol, D-8000 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Klin Orthopadie & Unfallchirurg, D-8000 Munich, Germany
[3] Klinikum Starnberg, Klin Orthopadie, Starnberg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2011年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 49 条
  • [41] FDG PET studies for the prediction of therapy outcome in patients with high risk soft tissue sarcomas receiving high dose chemotherapy with peripheral blood stem cell rescue (PBSCR)
    Dimitrakopoulou-Strauss, A.
    Kasper, B.
    Egerer, G.
    Haberkorn, U.
    Strauss, L. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S36 - S36
  • [42] Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis
    Falk Roeder
    Alexis Ulrich
    Gregor Habl
    Matthias Uhl
    Ladan Saleh-Ebrahimi
    Peter E Huber
    Daniela Schulz-Ertner
    Anna V Nikoghosyan
    Ingo Alldinger
    Robert Krempien
    Gunhild Mechtersheimer
    Frank W Hensley
    Juergen Debus
    Marc Bischof
    BMC Cancer, 14
  • [43] Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis
    Roeder, Falk
    Ulrich, Alexis
    Habl, Gregor
    Uhl, Matthias
    Saleh-Ebrahimi, Ladan
    Huber, Peter E.
    Schulz-Ertner, Daniela
    Nikoghosyan, Anna V.
    Alldinger, Ingo
    Krempien, Robert
    Mechtersheimer, Gunhild
    Hensley, Frank W.
    Debus, Juergen
    Bischof, Marc
    BMC CANCER, 2014, 14
  • [44] Reduction of Cyclophosphamide Dose for Patients With Subset 2 Low-Risk Rhabdomyosarcoma Is Associated With an Increased Risk of Recurrence: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group
    Walterhouse, David O.
    Pappo, Alberto S.
    Meza, Jane L.
    Breneman, John C.
    Hayes-Jordan, Andrea
    Parham, David M.
    Cripe, Timothy P.
    Anderson, James R.
    Meyer, William H.
    Hawkins, Douglas S.
    CANCER, 2017, 123 (12) : 2368 - 2375
  • [45] Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial (vol 6, pg 535, 2020)
    Martin-Broto, J.
    Hindi, N.
    Lopez-Pousa, A.
    JAMA ONCOLOGY, 2020, 6 (10) : 1641 - 1641
  • [46] DETERMINANTS OF TOXICITY, PATTERNS OF FAILURE, AND OUTCOME AMONG ADULT PATIENTS WITH SOFT TISSUE SARCOMAS OF THE EXTREMITY AND SUPERFICIAL TRUNK TREATED WITH GREATER THAN CONVENTIONAL DOSES OF PERIOPERATIVE HIGH-DOSE-RATE BRACHYTHERAPY AND EXTERNAL BEAM RADIOTHERAPY
    San Miguel, Inigo
    San Julian, Mikel
    Cambeiro, Mauricio
    Fernandez Sanmamed, Miguel
    Vazquez-Garcia, Blancav
    Pagola, Maria
    Gaztanaga, Miren
    Martin-Algarra, Salvador
    Martinez-Monge, Rafael
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : E529 - E539
  • [47] Shorter-Duration Therapy Using Vincristine, Dactinomycin, and Lower-Dose Cyclophosphamide With or Without Radiotherapy for Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group
    Walterhouse, David O.
    Pappo, Alberto S.
    Meza, Jane L.
    Breneman, John C.
    Hayes-Jordan, Andrea A.
    Parham, David M.
    Cripe, Timothy P.
    Anderson, James R.
    Meyer, William H.
    Hawkins, Douglas S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (31) : 3547 - +
  • [48] Short, full-dose neoadjuvant chemotherapy in localized high-risk adult soft tissue sarcomas (STS): An exploratory subgroup analysis on responding patients in a randomized controlled trial comparing 3 neoadjuvant versus 3 neoadjuvant+2 adjuvant cycles of full dose anthracycline and ifosfamide chemotherapy at a 10yr median FU.
    Stacchiotti, Silvia
    Pizzamiglio, Sara
    Messina, Antonella
    Morosi, Carlo
    Collini, Paola
    Llombart-Bosch, Antonio
    Broto, Javier Martin
    Comandone, Alessandro
    Cruz, Josefina
    Grignani, Giovanni
    Quagliuolo, Vittorio
    Picci, Piero
    De Paoli, Antonino
    Dei Tos, Angelo Paolo
    Verderio, Paolo
    Casali, Paolo Giovanni
    Gronchi, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] Shorter-Duration Therapy Using Vincristine, Dactinomycin, and Lower-Dose Cyclophosphamide With or Without Radiotherapy for Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group (vol 32, pg 3547, 2014)
    Walterhouse, D. O.
    Pappo, A. S.
    Meza, J. L.
    Breneman, J. C.
    Hayes-Jordan, A. A.
    Parham, D. M.
    Cripe, T. P.
    Anderson, J. R.
    Meyer, W. H.
    Hawkins, D. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) : 1459 - 1459
12345